MARAVAI LIFESCIENCES HOLDINGS, INC.
For the period ended Dec 31, 2024. Filed Mar 18, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 18, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report on to be signed on its behalf by the undersigned, thereunto duly authorized.
| Maravai LifeSciences Holdings, Inc. | |
| By: | /s/ William E. Martin, III |
| Name: | William E. Martin, III |
| Title: | Chief Executive Officer |
Date: March 18, 2025
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| Chief Executive Officer and Director (Principal Executive Officer) | March 18, 2025 | |
| /s/ William E. Martin, III | ||
| William E. Martin, III | ||
| /s/ Kevin Herde | Chief Financial Officer (Principal Financial and Accounting Officer) | March 18, 2025 |
| Kevin Herde | ||
| /s/ Robert Andrew Eckert | Chairman of the Board | March 18, 2025 |
| Robert Andrew Eckert | ||
| /s/ Sean Cunningham | Director | March 18, 2025 |
| Sean Cunningham | ||
| /s/ Benjamin Daverman | Director | March 18, 2025 |
| Benjamin Daverman | ||
| /s/ John DeFord | Director | March 18, 2025 |
| John DeFord, Ph.D. | ||
| /s/ Susannah Gray | Director | March 18, 2025 |
| Susannah Gray | ||
| /s/ Jessica Hopfield | Director | March 18, 2025 |
| Jessica Hopfield, Ph.D. | ||
| /s/ Gregory T. Lucier | Director | March 18, 2025 |
| Gregory T. Lucier | ||
| /s/ Luke Marker | Director | March 18, 2025 |
| Luke Marker | ||
| /s/ Constantine Mihas | Director | March 18, 2025 |
| Constantine Mihas | ||
| /s/ Murali K. Prahalad | Director | March 18, 2025 |
| Murali K. Prahalad, Ph.D. | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.